Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

IQ Ai Ltd (IQAIF)

IQ Ai Ltd (IQAIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0150 +33.33%
on 05/21/24
0.0200 unch
on 05/22/24
+0.0030 (+17.65%)
since 04/10/24
3-Month
0.0150 +33.33%
on 05/21/24
0.0200 unch
on 05/22/24
+0.0008 (+4.17%)
since 02/22/24

Most Recent Stories

More News
Imaging Biometrics Submits FDA 510(k) Application for IB Zero G

Patented Artificial Intelligence Technology Eliminates the Need for Gadolinium-Based Contrast Agents in MRI Exams

IQAI.LN : 0.825 (+3.12%)
IQAIF : 0.0200 (+33.33%)
IB Neuro's Quantitative Mapping Method Assesses Metastatic Tumors

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

IQAI.LN : 0.825 (+3.12%)
IQAIF : 0.0200 (+33.33%)
IQAI's Sponsored Phase I Clinical Trial is Open

MILWAUKEE, WI / ACCESSWIRE / March 10, 2022 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI) is pleased to announce that the sponsored Phase I clinical trial for oral gallium maltolate (GaM) is open for enrollment....

IQAI.LN : 0.825 (+3.12%)
IQAIF : 0.0200 (+33.33%)
Imaging Biometrics LLC - Letter to Shareholders

Imaging Biometrics, a subsidiary of IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI), discusses its most successful year on record. - Increases technology platform and expects record revenues - Rolls out Phase I...

IQAI.LN : 0.825 (+3.12%)
IQAIF : 0.0200 (+33.33%)
Imaging Biometrics and St. Jude Children's Hospital Enter Agreement

IB Zero G™ Technology May Benefit Imaging in Pediatric Patients MILWAUKEE, WI / ACCESSWIRE / November 11, 2021 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI), a developer of medical image processing platforms...

IQAI.LN : 0.825 (+3.12%)
IQAIF : 0.0200 (+33.33%)
MD Anderson Adopts IB Clinic for Brain Tumor Analysis

Installation Includes IB Neuro™ and IB DCE™ Software Purchase also Includes IB Clinic - Mac Edition MILWAUKEE, WI / ACCESSWIRE / November 2, 2021 / IQ-AI Limited (LSE:IQAI)(OTCQB:IQAIF), a developer...

IQAI.LN : 0.825 (+3.12%)
IQAIF : 0.0200 (+33.33%)
IQ-AI Letter to Shareholders

Company Enjoys Most Successful Year on Record Marked Increase in Revenue and Growing Technology Portfolio Sponsorship of a Phase I Clinical Trial MILWAUKEE, WI / ACCESSWIRE / October 28, 2021 / IQ-AI Limited...

IQAI.LN : 0.825 (+3.12%)
IQAIF : 0.0200 (+33.33%)

Key Turning Points

3rd Resistance Point 0.0200
2nd Resistance Point 0.0200
1st Resistance Point 0.0200
Last Price 0.0200
1st Support Level 0.0200
2nd Support Level 0.0200
3rd Support Level 0.0200

See More

52-Week High 0.0550
Fibonacci 61.8% 0.0397
Fibonacci 50% 0.0350
Fibonacci 38.2% 0.0303
Last Price 0.0200
52-Week Low 0.0150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar